According to Aytu BioScience 's latest financial reports and stock price the company's current Operating Margin is -114.08%. At the end of 2022 the company had an Operating Margin of -114.08%.
Year | Operating Margin | Change |
---|---|---|
2022 | -114.08% | 29.03% |
2021 | -88.42% | 79.37% |
2020 | -49.29% | -86.7% |
2019 | -370.64% | 33.15% |
2018 | -278.36% | -60.15% |
2017 | -698.58% | -36.48% |
2016 | -1,099.73% | -62.84% |
2015 | -2,959.45% | -52.05% |
2014 | -6,172.30% | 88.45% |
2013 | -3,275.31% | 1.71% |
2012 | -3,220.34% | |
2009 | -3,189.83% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Rollins ROL | 18.63% | -116.33% | ๐บ๐ธ USA |
Stride (K12 Education)
LRN | 8.71% | -107.63% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.